Navigation Links
Vitasoy Recorded Healthy Sales Growth for 1H FY2007/2008
Date:11/26/2007

margin stood at 59.0%, which is in line with the same period last year.

Hong Kong

In the Hong Kong market, Vitasoy continued its strong focus on product innovation and brand building, and recorded a 7.4% growth in domestic sales. The number of new products launched during the interim period was more than double the number of new products launched during the entire previous financial year. New Vitasoy products include VITASOY SAN SUI Tofu, VITASOY Jasmine Soya Bean Milk, reformulated VITASOY Chocolate Soya Bean Milk, VITA Double Chocolate Milk and VITA Less Sweet Lemon Tea. In addition, very hot weather during this year's summer months in Hong Kong stimulated healthy growth in all business segments, especially the on-the-go market. The water business also showed satisfactory sales growth, which was a result of effective selling strategy and market consolidation.

Mr. Lo said, "Our emphasis on building our brand, expanding our product portfolio, and launching effective marketing campaigns has strengthened our leading position in the local beverage market. In the 2nd half of the fiscal year, we will continue to invest in brand reinforcement and promotion of our core products and newly launched items. Despite the challenges brought by increasing raw material costs and inflationary pressure, we will closely monitor all developments and adopt appropriate cost management measures. In addition, we will plan our promotional strategy carefully, in order to capture opportunities for effective price increases brought about by the revived economy and general inflation."

Mainland China

Thanks to the successful strategy of "core business, core brand and core city", Vitasoy China maintained strong expansion during the interim period, reporting a significant sales growth of 68.5% over the same period last year.

"In spite of intensifying market competition, we are still able to maintain our leading position in the soymilk category in the Mainl
'/>"/>

SOURCE Vitasoy International Holdings Limited
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Vitasoy Promotes the Soy Breast Health Connection
2. Penn study finds pro-death proteins required to regulate healthy immune function
3. UCLA researchers identify markers that may predict diabetes in still-healthy people
4. Air pollution linked to cardiovascular risk indices in healthy young adults
5. Top Tips to Enjoy Healthy Latin Food Without Losing the Taste (Recipe)
6. Heart-Healthy Workouts Help Knees, Too
7. Finicky Felines Award Four Stars to New Wellness(R) Healthy Indulgence Everyday Entrees
8. Keeping Kids Healthy and Fit: The New York Kids Club Launches a Revolutionary New Fitness Program
9. LifeMasters Provides Tips for Maintaining a Healthy Blood Cholesterol Level
10. On September 7th Local Organizations Partner to Celebrate Healthy Steps
11. September is Healthy Aging Month
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...er & Olsen LLP has filed a,class action lawsuit ag..."Company") (Nasdaq: ARTC ) and certain of its off...istrict of Texas on behalf of all persons or,entit... January 24, 2008,through July 18, 2008 (the "Comm...or entities who purchased call options or sold put...
(Date:7/25/2008)... therapy may be due to genetic factors , ... challenges the long-held belief that the hepatiti...y to restore itself after HIV patients are treated.... , From 50 percent to 90 percent of HIV-infect...ous drug use is the main cause of both types of in...
(Date:7/25/2008)...ity.com announces the,availability of Trade Alerts... all of the daily trading notes for free by visiti...erts include: DUSA Pharmaceuticals Inc. (Nasdaq: ... MBRK ), NovaMed Inc. (Nasdaq:,NOVA), Adolor Corp....) and,Abaxis Inc. (Nasdaq: ABAX )., Join investo...
(Date:7/25/2008)...mprovements in Members, Health, ATLANTA, July 25 ...h,care quality management solutions for health pla...nto a long-term agreement with Wellmark, Inc. to,c...lity(SM) Incent and,Reward Best Practices initiati...are clinicians to promote improved quality health ...
Breaking Medicine News(10 mins):Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 2Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 3Health News:Study Disproves Belief That Hepatitis C Blunts HIV Drugs 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3
...a spectacle when she had epileptic seizures, almos... her fit//, her face had a scowl and a guttural si...she convulsed. This had led her to be named as "T...en Schneider, of Schneider Children's Hospital in ...
...n recommended for medical conditions such as endom...estyle choice for women who dislike menstruation o...sion safe and is it a reasonable lifestyle choice,... Psychologist in this week’s BMJ? Birth control o...
... with lethal and disabling conditions is illegal w...ctice vary between different countries. An edito...e? In the Netherlands, about 200,000 live births ...0-20 babies – mostly with severe congenital malfor...
...roats may benefit from having a tonsillectomy in t... is// still unclear, and any benefits have to be b... A small study of adults from Finland showed tha...the likelihood of further infection after 90 days,...
Other Medicine News:Health News:Should Menstrual Suppression Be a Lifestyle Choice? 2Health News:Should the UK Adopt Dutch Rules on Euthanasia in Newborn Babies? 2Health News:Is It Worth Having Surgery to Remove Your Tonsils? 2
(Date:7/22/2008)...- Strong efficacy results from a multi-center 293-...com , Toronto Stock Exchange Symbol: CYT, MONTRE...echnologies,Inc., the global leader in cryotherapy...unced that results previously presented from three...roduct, Arctic Front(R),were published earlier to...
(Date:7/22/2008)...tudy Demonstrates Feasibility and Efficacy of Trea...y Liver Cancer, SAN FRANCISCO, and YONGIN-SI, Sou...San Francisco, CA and Ottawa, Ontario), and its So...day that novel findings from,a Phase I clinical tr...nstrated that the product was well-tolerated and r...
(Date:7/22/2008)...SOUTH SAN FRANCISCO, Calif., July 22 /PRNewswire/ ...t it has completed patient enrollment,in its Phase...bility and,ammonia scavenging effects of HPN-100 (...henylbutyrate) in patients with urea cycle disorde...esults in the fourth quarter,of this year., (Logo...
(Date:7/22/2008)...SOPHIA ANTIPOLIS, France, July 22 /PRNewswire-Firs...nnounced it has successfully completed the,enrollm...olled hypertension,in two clinical pharmacology st...y announced timelines. These trials are designed t..., in comparison to ibuprofen and,naproxen, using t...
Breaking Medicine Technology:CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 2NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 3Nightingale announces US 2412 3 million sale of its Therapist Helper business 13183 1Nightingale announces US 2412 3 million sale of its Therapist Helper business 13183 2Nightingale announces US 2412 3 million sale of its Therapist Helper business 13183 3Nightingale announces US 2412 3 million sale of its Therapist Helper business 13183 4Congressman Walberg Awarded for Protecting Medicare Choices 13181 1Two Faced Particles Act Like Tiny Submarines 3636 1Two Faced Particles Act Like Tiny Submarines 3636 2Two Faced Particles Act Like Tiny Submarines 3636 3Computer simulations point to key molecular basis of cystic fibrosis 2364 1Computer simulations point to key molecular basis of cystic fibrosis 2364 2
...tatistically Significant Clinical Results for,SB-5...athy, CHICAGO, June 22, 2007 /PRNewswire-FirstCall... presentation of encouraging,Phase 1 clinical data...Scientific Sessions of the American Diabetes Assoc... entitled, "Improved,Neurologic Exam and Nerve Con...
... Symptoms Negatively Affect Relationship, BOCA RAT... a new,nationwide survey show that more than half ...dical condition known as low,testosterone incorrec...The survey also found that, while women believe th...gatively impact their,relationship, treatment of t...
Other Medicine Technology:Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 2Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 3Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 4Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 5Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 6Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 7Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 8Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 9New Poll Shows Men, Women Incorrectly Blame Symptoms of Low,Testosterone on Normal Aging 2New Poll Shows Men, Women Incorrectly Blame Symptoms of Low,Testosterone on Normal Aging 3New Poll Shows Men, Women Incorrectly Blame Symptoms of Low,Testosterone on Normal Aging 4New Poll Shows Men, Women Incorrectly Blame Symptoms of Low,Testosterone on Normal Aging 5
Specially designed for rugged use; perfect tool with power and endurance. Balance of weight and power helps reduce user fatigue. Internally lubricated for longer serivce. Switch is designed and place
De Soutter supply clean cast removal saws that are low in voltage and contain an integrated extractor system, combining state-of-the-art ergonomics with performance and durability.
...he osteotomy staples is quite similar to the type ...e the inner position of the anti recoil contours a...lique staples). There are 3 kinds of staples: 1.... staples can have 3 different widths: 20mm, 26 mm ...
...e Barium Sulfate USP is specifically designed to p...pabilities for todays medical professionals who ad...y. Comprised of a uniform particle size, Biotrace ...lting in a consistent visualization of bone cement...
Medicine Products: